CD44 and metastatic malignant neoplasm in the lymph nodes: Since tumors expressing CD44 were significantly more likely to be lymph node metastasis than CD44-negative tumors, the joint effects of CD44 status and lymph node metastasis on survival were assessed by Kaplan–Meier analysis, stratifying for CD44 status (positive vs.